Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

In case you haven't had enough artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight ...

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

This story is from the next print edition of MIT Technology Review, which explores power—who has it, and who wants it. It’s ...